bioAffinity Technologies, Inc. Warrant reported a net loss of $14.9M in fiscal year 2025. This represents a decrease of 64.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $15.2M net loss. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters bioAffinity Technologies, Inc. Warrant has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BIAFW Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
BIAFW Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More bioAffinity Technologies, Inc. Warrant financials
Frequently Asked Questions
What was bioAffinity Technologies, Inc. Warrant's net income in fiscal year 2025?
bioAffinity Technologies, Inc. Warrant reported a net loss of $14.9M in fiscal year 2025.
How fast is bioAffinity Technologies, Inc. Warrant's net income growing?
bioAffinity Technologies, Inc. Warrant (BIAFW) net income fell by 64.9% year over year, from -$9.0M to -$14.9M in fiscal year 2025.
What is bioAffinity Technologies, Inc. Warrant's net income over the last twelve months?
bioAffinity Technologies, Inc. Warrant (BIAFW) reported a $15.2M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has bioAffinity Technologies, Inc. Warrant's net income changed over the years?
Across the 5 fiscal years this page covers, bioAffinity Technologies, Inc. Warrant (BIAFW) net income went from -$6.3M in fiscal year 2021 to -$14.9M in fiscal year 2025.
What was bioAffinity Technologies, Inc. Warrant's net income in the most recent quarter?
bioAffinity Technologies, Inc. Warrant (BIAFW) reported -$3.4M in net income in Q2 2026. This represents an increase of 17.1% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what bioAffinity Technologies, Inc. Warrant (BIAFW) reported on that line in every period on record.